Ryu Tiger, Y. K., Jain, S., Barta, S. K., Tolu, S., Estrella, B., Sawas, A., Lue, J. K., Francescone, M. M., Pro, B., & Amengual, J. E. (2024). Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma. Leukemia & Lymphoma, 65(6), 736–745. https://doi.org/10.1080/10428194.2024.2329996

Oiwa, K., Hosono, N., Nishi, R., Scotto, L., O’Connor, O. A., & Yamauchi, T. (2021). Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance. BMC Cancer, 21(1). https://doi.org/10.1186/s12885-021-08607-9